查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1753933

2025-2033年兽用疫苗市场报告（依疫苗类型、技术、给药途径、配销通路及地区）

Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球兽用疫苗市场规模达147亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到296亿美元，2025-2033年期间的复合年增长率（CAGR）为7.71%。市场成长主要源自于人们对兽医保健日益增长的关注、牲畜保险需求以及新型兽医疫苗的推出。目前，北美占据市场主导地位，因为该地区宠物主人数量不断增加、兽医保健基础设施先进，畜牧业规模庞大。

兽用疫苗是指经由肠外或口服途径给予家畜或野生动物的生物製剂免疫，以刺激保护性免疫反应，而不会引发疾病本身。兽用疫苗包括灭活疫苗、减毒活疫苗和重组疫苗等常见疫苗。这些疫苗有助于减轻动物痛苦，增强免疫力，并预防各种传染性人畜共通传染病的发生和传播风险。

兽用疫苗市场趋势：

兽医保健日益受到关注

根据IMARC集团的报告，全球兽医保健市场规模在2023年达到433亿美元。随着越来越多的人成为宠物主人，他们也更加重视宠物的健康，增加了兽医预约和预防性治疗的次数。疫苗接种是保持宠物健康的重要方面，这推动了对兽医疫苗的需求。大众越来越意识到预防动物疾病而非仅仅治疗疾病的必要性，这为兽医疫苗市场提供了良好的前景。疫苗接种是一种非常有效的预防措施，使其成为伴侣动物和牛隻兽医保健方案的重要组成部分。宠物主人和牲畜生产者愿意在医疗保健方面（包括疫苗）支付更多费用，以预防可能损害动物健康和生产力的疾病。这种趋势正在催化对各种免疫接种的需求，尤其是在兽医服务变得越来越容易获得的情况下。

牲畜保险需求不断增长

IMARC集团的报告显示，2023年全球牲畜保险市场规模达36亿美元。许多牲畜保险单要求接种常见疾病疫苗作为承保条件。投保的农民和牲畜所有者有动力为他们的牲畜接种疫苗以履行保单义务，这对兽用疫苗市场份额产生了积极影响。牲畜保险通常用于降低因疾病、意外或自然灾害造成的牲畜损失相关的财务风险。为牲畜接种疫苗的农民降低了疾病爆发的风险，使他们的牲畜更容易投保，并降低了索赔的可能性。这鼓励了定期接种疫苗，从而增加了疫苗需求。

新品发布

新型兽用疫苗正在研发中，用于对抗正在发展中的疾病以及新发现的动物病原体。随着先前未知或正在发展的疾病的爆发，对新型疫苗的需求不断增长，从而推动了兽用疫苗市场的成长。重组疫苗、DNA疫苗和基于载体的疫苗等新一代疫苗，提高了动物疾病预防的有效性和安全性。这些新型疫苗通常更有效、副作用更少、保护期更长，因此对医生和宠物主人更具吸引力。新推出的疫苗通常一次注射即可覆盖多种疾病或病毒株，让兽医和宠物主人的工作更加轻鬆。

本报告回答的关键问题：

  • 全球兽用疫苗市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对全球兽用疫苗市场有何影响？
  • 主要的区域市场有哪些？
  • 根据疫苗类型，市场如何分布？
  • 基于技术的市场区隔是怎样的？
  • 根据行政路径，市场如何划分？
  • 根据配销通路，市场如何划分？
  • 该产业的价值链分为哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球兽用疫苗市场的结构是怎么样的？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球兽用疫苗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依疫苗类型

  • 牲畜疫苗
    • 关键部分
      • 牛疫苗
      • 家禽疫苗
      • 猪疫苗
      • 其他的
  • 伴侣动物疫苗
    • 关键部分
      • 犬类疫苗
      • 猫疫苗
      • 马疫苗

第七章：市场区隔：依技术

  • 减毒活疫苗
  • 灭活疫苗
  • 类毒素疫苗
  • 重组疫苗
  • 其他的

第八章：市场区隔：依行政途径

  • 皮下
  • 肌肉注射
  • 鼻内

第九章：市场区隔：按配销通路

  • 兽医院
  • 兽医诊所
  • 药局和药局
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Elanco Animal Health Incorporated
    • Hester Biosciences Limited
    • HIPRA
    • Indian Immunologicals Limited
    • Merck & Co. Inc.
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Virbac SA
    • Zoetis Inc.
Product Code: SR112025A6493

The global veterinary vaccines market size reached USD 14.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033. The market is driven primarily because of the growing focus on veterinary healthcare, need for livestock insurance and the launch of new veterinary vaccinations. At present, North America dominates the market because of the rising number of pet parents, advanced veterinary healthcare infrastructure, and significant livestock industry.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases.

Veterinary Vaccines Market Trends:

Growing focus on veterinary healthcare

According to the IMARC Group's report, the global veterinary healthcare market reached USD 43.3 Billion in 2023. As more individuals are becoming pet parents, there is a greater emphasis on their well-being, resulting in increased veterinary appointments and preventive treatment. Vaccinations are an important aspect of keeping pets healthy, which is driving the demand for veterinary vaccinations. The growing awareness among the masses about the necessity of preventing animal diseases rather than simply treating them is offering a favorable veterinary vaccines market outlook. Vaccination is a very efficient preventive measure, making it an essential component of veterinary healthcare regimens for both companion animals and cattle. Pet parents and livestock producers are willing to pay more on healthcare, including vaccines, to prevent diseases that could harm animal health and productivity. This tendency is catalyzing the demand for a wide variety of immunizations, particularly as veterinary services become more accessible.

Increasing demand for livestock insurance

The IMARC Group's report shows that the global livestock insurance market reached USD 3.6 Billion in 2023. Many livestock insurance policies demand vaccinations against common diseases as a condition of coverage. Insured farmers and livestock owners are incentivized to vaccinate their animals to meet policy obligations, which is positively influencing the veterinary vaccines market share. Livestock insurance is generally used to reduce the financial risks connected with livestock loss caused by disease, accidents, or natural catastrophes. Farmers who vaccinate their animals lessen the chance of disease outbreaks, making their livestock more insurable and lowering the possibility of claims. This encourages regular vaccinations, which increases vaccine demand.

New launches

New veterinary vaccinations are being produced to combat developing diseases and newly discovered pathogens impacting animals. As outbreaks of previously unknown or developing illnesses are arising, the demand for novel vaccines is rising, thereby propelling veterinary vaccines market growth. Next-generation vaccines, such as recombinant, DNA, and vector-based vaccinations, improve the efficacy and safety of disease prevention in animals. These new vaccines are frequently more effective, have fewer side effects, and give longer-lasting protection, making them more appealing to physicians and pet owners. New releases frequently feature vaccines that cover many diseases or strains in a single shot, making life easier for vets and owners.

Key Market Segmentation:

Breakup by Vaccine Type:

  • Livestock Vaccines
    • Bovine Vaccines
    • Poultry Vaccines
    • Porcine Vaccines
    • Others
  • Companion Animal Vaccines
    • Canine Vaccines
    • Feline Vaccines
    • Equine Vaccines

Breakup by Technology:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others

Breakup by Route of Administration:

  • Subcutaneous
  • Intramuscular
  • Intranasal

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global veterinary vaccines market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Virbac SA
  • Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global veterinary vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Livestock Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bovine Vaccines
      • 6.1.2.2 Poultry Vaccines
      • 6.1.2.3 Porcine Vaccines
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Companion Animal Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Canine Vaccines
      • 6.2.2.2 Feline Vaccines
      • 6.2.2.3 Equine Vaccines
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Attenuated Live Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Inactivated Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxoid Vaccines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Recombinant Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Subcutaneous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Intranasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Veterinary Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmacies and Drug Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Sante Animale
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco Animal Health Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Hester Biosciences Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 HIPRA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indian Immunologicals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Neogen Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phibro Animal Health Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Virbac SA
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Zoetis Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials

List of Figures

  • Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2024
  • Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
  • Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
  • Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
  • Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Veterinary Vaccines Market: Competitive Structure
  • Table 8: Global: Veterinary Vaccines Market: Key Players